(Memantin) is a medication that improves brain metabolism. It provides protection of cells from the toxic effect of amino acids with an exciting effect, affects the metabolism of t-protein. Akatinol Memantine is a psychoanaleptics, which treats diseases of the nervous system, dementia. It belongs to the nootropic and neuroprotective agents. It is a drug that improves brain metabolism. Akatinol Memantine is taken with a decrease in memory and the ability to concentrate, increased fatigue, traumatic brain injuries and a number of other diseases associated with a violation of the brain. It is used to help patients with Alzheimer's and Parkinson's diseases, multiple sclerosis and other neurological disorders.
Dementia of different degrees of severity (Alzheimer's, mixed, vascular types)
Disorders of the nervous system (memory impairment, attention to detail, fatigue, loss of interest, confusion
Cerebral and spinal spastic syndromes due to the suffered traumatic brain and birth injuries, sclerosis, stroke
Warranty & Expiration Date
100% Original AKATINOL MEMANTINE .
Produced by: Merz Pharma GmbH & Co. KGaA.
Expiration date up to 02.2022.
Akatinol Memantine is produced in the form of pills.
Main ingredient : memantine hydrochloride – 20mg.
Excipients: lactose, MCC, colloidal silicon dioxide, talc, magnesium stearate.
The pill should be administrated orally with eating in the morning. The initial dose for the 1st week is 5mg/day, 2nd week – 10mg/day, 3rd week – 15-20mg/day. If it is required – increase the dose for 10mg every week till the maximum 30mg/day.
Hypersensitivity to the drug, severe renal failure (creatinine clearance 5-29 ml/min), severe liver failure, pregnancy, breastfeeding, children under 18 years (due to insufficient data).
On the part of the body as a whole-General adverse reactions. Common: headache; rare: fatigue. Infections. Rarely: fungal infections. Mental disorder. Often: drowsiness; rarely: confusion, hallucinations; frequency not established: psychotic reactions. Disorders of the cardiovascular system. Rarely: hypertension, venous thrombosis / thromboembolism. Gastrointestinal disorders. Often: constipation; rarely: nausea, vomiting; frequency not established: pancreatitis. Disorders of the Central and peripheral nervous system. Often: dizziness; rare: gait disturbance; very rare: seizures. Hallucinations were observed mainly in patients with Alzheimer's disease at the stage of severe dementia.
Store in dry place at room temperature. Do not exceed storage temperature higher than 25 degrees Celcius. Keep away from direct sunlight. Keep locked and away from children.
Caution: Consult your physician if taking medications or have a medical condition.
Please connect with us if you need more information about AKATINOL MEMANTINE.